PT94992A - Processo para a preparacao de polipeptidos mutantes de interleucina-3-humana - Google Patents

Processo para a preparacao de polipeptidos mutantes de interleucina-3-humana

Info

Publication number
PT94992A
PT94992A PT199094992A PT9499290A PT94992A PT 94992 A PT94992 A PT 94992A PT 199094992 A PT199094992 A PT 199094992A PT 9499290 A PT9499290 A PT 9499290A PT 94992 A PT94992 A PT 94992A
Authority
PT
Portugal
Prior art keywords
mutants
deletion
residues
coding sequence
biological activity
Prior art date
Application number
PT199094992A
Other languages
English (en)
Other versions
PT94992B (pt
Inventor
Christiaan Joannes Dorssers Lambertus
Willem Van Leen Robert
Original Assignee
Gist Brocades Nv.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26121243&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT94992(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gist Brocades Nv. filed Critical Gist Brocades Nv.
Publication of PT94992A publication Critical patent/PT94992A/pt
Publication of PT94992B publication Critical patent/PT94992B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5403—IL-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT94992A 1989-08-14 1990-08-14 Processo para a preparacao de polipeptidos mutantes de interleucina-3-humana PT94992B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP89202082 1989-08-14
EP89202331 1989-09-14

Publications (2)

Publication Number Publication Date
PT94992A true PT94992A (pt) 1991-04-18
PT94992B PT94992B (pt) 1997-09-30

Family

ID=26121243

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94992A PT94992B (pt) 1989-08-14 1990-08-14 Processo para a preparacao de polipeptidos mutantes de interleucina-3-humana

Country Status (17)

Country Link
EP (2) EP0413383B1 (pt)
JP (1) JP3192416B2 (pt)
AT (1) ATE154638T1 (pt)
AU (1) AU636641B2 (pt)
CA (1) CA2023246C (pt)
DD (1) DD301724A9 (pt)
DE (1) DE69030937T2 (pt)
DK (1) DK0413383T3 (pt)
ES (1) ES2106017T3 (pt)
FI (1) FI105192B (pt)
GR (1) GR3024679T3 (pt)
HU (1) HUT54411A (pt)
IE (2) IE902921A1 (pt)
IL (1) IL95350A0 (pt)
NO (1) NO301481B1 (pt)
NZ (1) NZ234869A (pt)
PT (1) PT94992B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE179211T1 (de) * 1991-10-07 1999-05-15 Medvet Science Pty Ltd Menschliche il-3-varianten
US6361977B1 (en) * 1992-11-24 2002-03-26 S. Christopher Bauer Methods of using multivariant IL-3 hematopoiesis fusion protein
US5738849A (en) * 1992-11-24 1998-04-14 G. D. Searle & Co. Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them
US6153183A (en) * 1992-11-24 2000-11-28 G. D. Searle & Company Co-administration of interleukin-3 mutant polypeptides with CSF's or cytokines for multi-lineage hematopoietic cell production
DK0672145T3 (da) * 1992-11-24 2003-08-11 Searle & Co Interleukin-3-(IL-3)-polypeptider med flere mutationer
US6361976B1 (en) 1992-11-24 2002-03-26 S. Christopher Bauer Co-administration of interleukin-3 mutant polypeptides with CSF'S for multi-lineage hematopoietic cell production
US6413509B1 (en) 1992-11-24 2002-07-02 S. Christopher Bauer Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 mutant polypeptides with other hematopoietic growth factors
US6403076B1 (en) 1992-11-24 2002-06-11 S. Christopher Bauer Compositions for increasing hematopoiesis with interleukin-3 mutants
US5772992A (en) * 1992-11-24 1998-06-30 G.D. Searle & Co. Compositions for co-administration of interleukin-3 mutants and other cytokines and hematopoietic factors
US6057133A (en) * 1992-11-24 2000-05-02 G. D. Searle Multivariant human IL-3 fusion proteins and their recombinant production
US5501962A (en) * 1993-06-21 1996-03-26 G. D. Searle & Co. Interleuken-3 (IL-3) human/murine hybrid polypeptides and recombinant production of the same
SG52238A1 (en) * 1993-07-28 1998-09-28 Medvet Science Pty Ltd Haemopoietic growth factor antagonists
US6465616B1 (en) 1994-04-08 2002-10-15 Bresagen Limited Interleukin-5 antagonist
US6017523A (en) * 1995-06-06 2000-01-25 G.D. Searle & Co. Therapeutic methods employing mutant human interleukin-3 (IL-3) polypeptides
US6270758B1 (en) 1998-10-08 2001-08-07 Duke University Substantially non-toxic biologically active mucosal adjuvants in vertebrate subjects
JP4735670B2 (ja) * 2008-06-11 2011-07-27 富士ゼロックス株式会社 プリント基板および画像処理装置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR871029B (en) 1986-07-14 1987-11-02 Genetics Inst Novel osteoinductive factors
ATE161882T1 (de) 1986-12-16 1998-01-15 Gist Brocades Nv Molekulare klonierung und expression von menschlichem il-3
EP0275598B1 (en) 1986-12-16 1998-01-07 Gist-Brocades N.V. Molecular cloning and expression of human IL-3
EP0342206A4 (en) 1987-01-20 1990-09-19 Immunex Corporation Human interleukin-3 proteins
US4743264A (en) * 1987-02-05 1988-05-10 Sherva Parker Carole J External prothesis with magnetic field
OA09736A (en) 1987-02-18 1993-11-30 Schering Biotech Corp "Human interleukin-3 and muteins thereof".

Also Published As

Publication number Publication date
NZ234869A (en) 1991-12-23
AU6096090A (en) 1991-02-14
ATE154638T1 (de) 1997-07-15
JP3192416B2 (ja) 2001-07-30
EP0413383A1 (en) 1991-02-20
PT94992B (pt) 1997-09-30
ES2106017T3 (es) 1997-11-01
JPH0420295A (ja) 1992-01-23
NO301481B1 (no) 1997-11-03
DE69030937D1 (de) 1997-07-24
EP0810285A3 (en) 1998-07-08
EP0413383B1 (en) 1997-06-18
FI105192B (fi) 2000-06-30
CA2023246A1 (en) 1991-02-15
IE902921A1 (en) 1991-02-27
DK0413383T3 (da) 1997-07-07
IL95350A0 (en) 1991-06-30
CA2023246C (en) 2002-02-19
NO903544L (no) 1991-02-15
HUT54411A (en) 1991-02-28
AU636641B2 (en) 1993-05-06
IE980055A1 (en) 2000-02-23
DE69030937T2 (de) 1997-10-09
EP0810285A2 (en) 1997-12-03
FI903996A0 (fi) 1990-08-13
DD301724A9 (de) 1993-08-12
NO903544D0 (no) 1990-08-13
GR3024679T3 (en) 1997-12-31

Similar Documents

Publication Publication Date Title
PT94992A (pt) Processo para a preparacao de polipeptidos mutantes de interleucina-3-humana
DE3588225T2 (de) Anti-Lymphotoxin-Antikörper, Herstellung und Verwendung
EP1283264A3 (en) Interleukin-3 (IL-3) mutant polypeptides
CN1294596A (zh) 修饰蛋白的免疫原性
KR890003802A (ko) 재조합 dna 기술에 의해 제조된 소의 췌장 트립신 억제제, 그 제조 방법, 발현 벡터 및 재조합 숙주 및 그의 제약적 용도
GR3034140T3 (en) CD2-Binding domain of lymphocyte function associated antigen 3.
JP2003530839A5 (pt)
AU7565991A (en) Variant cd44 surface proteins, dna sequences coding them, antibodies against these proteins and their use in diagnosis and therapy
DE JONG et al. Primary Structures of the α‐Crystallin A Chains of Seven Mammalian Species
RU93045577A (ru) Слитные полипептиды
Davis et al. Basic fibroblast growth factor induces 3T3 fibroblasts to synthesize and secrete a cyclophilin-like protein and β2-microglobulin
AU2650597A (en) Novel fas antigen derivatives
IE850614L (en) Cloning of interleukin
HUT69169A (en) T-cell-suppressive peptide fragments of human myelin basic protein (hmbp) and pharmaceutical compositions containing them
EP0307513A3 (en) Pulmonary hydrophobic surfactant-associated proteins
Herzbeck et al. Functional and Molecular Characterization of a Monoclonal Antibody against the 165–186 Peptide of Human 1β
WO1991010684A1 (en) Oxidized variants of gm-csf
ES2055095T3 (es) Linfotoxina humana.
KR930701600A (ko) 안정적이고 생물활성적인 변형된 소마토트로핀
CA2083286A1 (en) Recombinant fibrinogenases, preparation and use thereof
Dukovich The Purification and Biochemical Characterization of Natural and Recombinant Interleukin 1
CA2269085A1 (en) Rainbow trout il1.beta.; encoding nucleic acid; materials and methods

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19901113

FG3A Patent granted, date of granting

Effective date: 19970630

PC3A Transfer or assignment

Free format text: 19981117 DSM N.V. NL

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20031231